Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting

American Heart Journal

Volumn 154, Issue 5, 2007, Pages 995-1002

  Gibson, Patrick H ^a   Croal, Bernard L ^a   Cuthbertson, Brian H ^b   Small, Gary R ^a   Ifezulike, Adaeze I ^a   Gibson, George ^a   Jeffrey, Robert R ^a   Buchan, Keith G ^a   El Shafei, Hussein ^a   Hillis, Graham S ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

AGED; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MYOCARDIAL ISCHEMIA; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 35448936082     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.06.043     Document Type: Article

References (35)

1. Bridgewater B., Grayson A.D., Jackson M., et al. Surgeon specific mortality in adult cardiac surgery: comparison between crude and risk stratified data. BMJ 327 (2003) 13-17
2. Hansson G. Inflammation, atherosclerosis, and coronary heart disease. N Engl J Med 352 (2005) 1685-1695
3. Danesh J., Collins R., Appleby P., et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
4. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
5. Phillips A.N., Neaton J.D., Cook D.G., et al. Leukocyte count and risk of major coronary heart disease events. Am J Epidemiol 136 (1992) 59-70
6. Kannel W.B., Anderson K., and Wilson P.W. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 267 (1992) 1253-1256
7. Hajj-Ali R., Zareba W., Ezzeddine R., et al. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol 88 (2001) 1221-1224
8. Schlant R.C., Forman S., Stamler J., et al. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project. Circulation 66 (1982) 401-414
9. Sabatine M.S., Morrow D.A., Cannon C.P., et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 substudy. J Am Coll Cardiol 40 (2002) 1761-1768
10. Barron H.V., Harr S.D., Radford M.J., et al. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 38 (2001) 1654-1661
11. Bagger J.P., Zindrou D., and Taylor K.M. Leukocyte count: a risk factor for coronary artery bypass graft mortality. Am J Med 115 (2003) 660-663
12. Dacey L.J., DeSimone J., Braxton J.H., et al. Preoperative white blood cell count and mortality and morbidity after coronary artery bypass grafting. Ann Thorac Surg 76 (2003) 760-764
13. Newall N., Grayson A.D., Oo A.Y., et al. Preoperative white blood cell count is independently associated with higher perioperative cardiac enzyme release and increased 1-year mortality after coronary artery bypass grafting. Ann Thorac Surg 81 (2006) 583-589
14. Gurm H.S., Bhatt D.L., Lincoff A.M., et al. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 89 (2003) 1200-1204
15. Coller B.S. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?. Arterioscler Thromb Vasc Biol 25 (2005) 658-670
16. Folsom A.R., Wu K.K., Rosamond W.D., et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96 (1997) 1102-1108
17. Madjid M., Awan I., Willerson J.T., et al. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44 (2004) 1945-1956
18. Kawaguchi H., Mori T., Kawano T., et al. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J 132 (1996) 9-12
19. Grau A.J., Boddy A.W., Dukovic D.A., et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 35 (2004) 1147-1152
20. Sweetnam P.M., Thomas H.F., Yarnell J.W., et al. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 145 (1997) 416-421
21. Ommen S.R., Hodge D.O., Rodeheffer R.J., et al. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 97 (1998) 19-22
22. Ommen S.R., Gibbons R.J., Hodge D.O., et al. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol 79 (1997) 812-814
23. Horne B.D., Anderson J.L., John J.M., et al. Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol 45 (2005) 1638-1643
24. Duffy B.K., Gurm H.S., Rajagopal V., et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 97 (2006) 993-996
25. Upadhya B., Applegate R.J., Sane D.C., et al. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol 96 (2005) 515-518
26. Harris N., Jou J.M., Devoto G., et al. Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial. Lab Hematol 11 (2005) 62-70
27. De Maria R., Mazzoni M., Parolini M., et al. Predictive value of EuroSCORE on long term outcome in cardiac surgery patients: a single institution study. Heart 91 (2005) 779-784
28. Biancari F., Kangasniemi O.P., Luukkonen J., et al. EuroSCORE predicts immediate and late outcome after coronary artery bypass surgery. Ann Thorac Surg 82 (2006) 57-61
29. Grzybowski M., Welch R.D., Parsons L., et al. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. Acad Emerg Med 11 (2004) 1049-1060
30. Gurm H.S., Bhatt D.L., Gupta R., et al. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J 146 (2003) 692-698
31. Stewart R.A., White H.D., Kirby A.C., et al. Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Investigators. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin. Circulation 111 (2005) 1756-1762
32. Croal B.L., Hillis G.S., Gibson P.H., et al. The relationship between post-operative cardiac troponin I levels and outcome from cardiac surgery. Circulation 114 (2006) 1468-1475
33. Cooper H.A., Exner D.V., Waclawiw M.A., et al. White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol 84 (1999) 252-257
34. Gasz B., Lenard L., Benko L., et al. Expression of CD97 and adhesion molecules on circulating leukocytes in patients undergoing coronary artery bypass surgery. Eur Surg Res 37 (2005) 281-289
35. Naruko T., Ueda M., Haze K., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106 (2002) 2894-2900